Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1885 3
1886 3
1887 3
1891 1
1895 7
1896 5
1898 2
1899 3
1900 1
1904 2
1906 2
1907 2
1909 1
1912 1
1917 1
1919 1
1920 3
1922 1
1928 1
1948 2
1950 1
1963 1
1965 1
1966 1
1967 2
1968 2
1969 3
1970 4
1972 9
1973 25
1974 30
1975 12
1976 1
1981 1
1982 1
1986 2
1987 8
1988 6
1989 6
1990 11
1991 3
1992 4
1993 3
1995 4
1996 1
1997 2
1998 2
1999 1
2002 1
2003 1
2006 2
2008 6
2009 4
2010 6
2011 7
2012 12
2013 19
2014 24
2015 21
2016 33
2017 34
2018 44
2019 43
2020 71
2021 78
2022 96
2023 119
2024 171
2025 213
2026 186

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,253 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Jackson-Harris
Page 1
Introduction.
Bhardwaj P, C MN. Bhardwaj P, et al. Among authors: c mn. J Hand Surg Asian Pac Vol. 2025 Aug;30(4):333. doi: 10.1142/S2424835525010052. Epub 2025 Jul 25. J Hand Surg Asian Pac Vol. 2025. PMID: 40721244 No abstract available.
Factors associated with the choice of treatment for coronoid fractures.
de Klerk HH, Verweij LPE, Doornberg JN, Jaarsma RL, Murase T, Chen NC, van den Bekerom MPJ; and the Elbow Injury Management Consortium; and the Elbow Injury Management Consortium (EIMC); Al K, Ar B, Ac W, A VT, Ac AP, A T, A B, B M, B T, B J, Cs M, Cm L, Cg L, Cg T, C R, D R, Ds R, D E, E AG, E K, Et E, Gi B, Jn L, Ja W, J P, J A, K S, K S, Al B, Ms C, M M, Ml R, Mj S, N A, N W, Nwl S, P A, P M, R B, Rj T, R VR, R G, S S, Sd D, S T, T M, Y C. de Klerk HH, et al. Among authors: c r. Bone Joint J. 2024 Oct 1;106-B(10):1150-1157. doi: 10.1302/0301-620X.106B10.BJJ-2024-0359.R1. Bone Joint J. 2024. PMID: 39348906
Sitagliptin, Metformin and Glimepiride Fixed-Dose Combination Compared to Co-Administration of Metformin and High-Dose Glimepiride in Indian Patients With Type 2 Diabetes: A Randomised, Double-Blind, Double-Dummy, Phase 3 Clinical Study.
Sahay R, Gowda A, Singh MK, Rao AG, Duraisamy R, Gangwani D, Shukla J, Agarwal V, Patil SS, C A, K N SB, Palawat A, Gofne SK, Sahoo AK, Rai PK, Shaikh R, Saha S, Patil D, Ghadge P, Patel P, Lakhwani L, Mehta S, Joglekar S. Sahay R, et al. Among authors: c a. Diabetes Obes Metab. 2026 Jul;28(7):6207-6216. doi: 10.1111/dom.70778. Epub 2026 May 3. Diabetes Obes Metab. 2026. PMID: 42070788 Free PMC article. Clinical Trial.
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study).
C A, Kundan Lal Lila AR, Parikh A, Mangipudi A, Sonawane A, Kiran BH, Das B, Chopde C, Varade D, C M, Bhagwat N, Bastewad N, Shah P, Saxena P, Balamurugan R, Sahay RK, Giri R, Das S, Gupta SK, Mehendiratta S, Saran S, Saklecha S, Jethwa S, Bhandari S, Kongara S, Anjum S, Gupta S, Shah T, Chavda V, Chaturvedi A, Ch A, Zaveri H, Nayak M, Kalkoti V. C A, et al. Among authors: c m. Metabol Open. 2026 Aug 5;31:100489. doi: 10.1016/j.metop.2026.100489. eCollection 2026 Sep. Metabol Open. 2026. PMID: 42598626 Free PMC article.
Case Report: Hyperandrogenism in Menopause.
F V, F G, G C, M B, C G, D S, S E O. F V, et al. Among authors: c g. Endocr Metab Immune Disord Drug Targets. 2024 Jul 26. doi: 10.2174/0118715303322604240722102207. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 39069804
1,253 results